Journal article
Epinephrine Autoinjectors: New Data, New Problems
Abstract
Epinephrine is the first-line treatment for anaphylaxis. Despite this, there have been identified gaps in the management of anaphylaxis including infrequent or delayed use of epinephrine for acute allergic reactions, as well as inadequate epinephrine autoinjector (EAI) training, and prescription rates of these devices for patients at risk. This paper reviews new data, and new problems in recently published literature on EAIs. A database search …
Authors
Waserman S; Avilla E; Ben-Shoshan M; Rosenfield L; Adcock AB; Greenhawt M
Journal
The Journal of Allergy and Clinical Immunology In Practice, Vol. 5, No. 5, pp. 1180–1191
Publisher
Elsevier
Publication Date
September 2017
DOI
10.1016/j.jaip.2017.06.027
ISSN
2213-2198